Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584 alone and concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus for near vision).

Inclusion Criteria:

-Presbyopia in each eye that impacts daily activities.

Exclusion Criteria:

• Use of any topical ophthalmic medications, including artificial tears
• Contact lens use in either eye within 14 days or planned use during the study
• History of eye surgery
• Diagnosis of any type of glaucoma or ocular hypertension